Characteristic | Univariate analysis OR (95% CI) | P value | Multivariate analysis OR (95% CI) | P value |
Age | 1.94 (1.11 to 3.41) | 0.021 | 0.96 (0.94 to 0.98) | <0.001 |
Gender | 0.97 (0.96 to 0.99) | 0.002 | 0.796 | |
Education level | 0.79 | |||
Employment status | 0.95 | |||
IBD diagnosis | 0.20 | |||
Age at IBD diagnosis | 0.98 (0.96 to 0.99) | 0.009 | 0.297 | |
Current steroid use | 0.161 | |||
Immunomodulator (IM) and biological use | ||||
No IM or biologics | Index | 0.014 | 0.008 | |
Combination therapy | 0.92 (0.47 to 1.83) | 0.819 | 0.69 (0.31 to 1.53) | 0.357 |
IM monotherapy | 0.33 (0.16 to 0.69) | 0.003 | 0.26 (0.11 to 0.58) | 0.001 |
Biologics monotherapy | 0.76 (0.39 to 1.46) | 0.408 | 0.76 (0.35 to 1.66) | 0.495 |
IBD medication knowledge | 0.71 | |||
IBD medication compliance | 0.16 | |||
Symptom status: | ||||
No symptoms | Index | Index | ||
Mild | 2.08 (1.17 to 3.69) | 0.012 | 1.74 (0.90 to 3.36) | 0.099 |
Moderate | 3.48 (1.69 to 7.17) | 0.001 | 3.89 (1.69 to 8.93) | 0.001 |
Severe | 4.03 (1.77 to 9.17) | 0.001 | 3.97 (1.52 to 10.4) | 0.005 |
Usual caregiver | ||||
IBD clinic | Index | 0.439 | ||
General Gastroenterology clinic | 3.28 (1.53 to 7.05) | 0.002 | ||
Surgeon (Public & Private) | 0.77 (0.12 to 4.84) | 0.78 | ||
Private Gastroenterologist | 2.12 (1.24 to 3.64) | 0.006 | ||
General Physician | 1.54 (0.59 to 4.04) | 0.382 | ||
Lack of access to IBD nurse | 1.65 (1.05 to 2.60) | 0.031 | 1.81 (1.03 to 3.19) | 0.04 |
Access to gastroenterologist phone-based review | 0.211 | |||
Lack of advice from medical practitioner regarding reducing COVID-19 infection risk | 1.74 (1.01 to 2.76) | 0.018 | 1.99 (1.13 to 3.50) | 0.017 |
Perceived increased susceptibility to COVID-19 compared with general population: | ||||
Strongly agree | Index | Index | ||
Agree | 0.73 (0.42 to 1.27) | 0.268 | 0.71 (0.38 to 1.35) | 0.302 |
Neither agree nor disagree | 0.32 (0.17 to 0.61) | 0.001 | 0.22 (0.10 to 0.48) | <0.001 |
Disagree | 0.24 (0.82 to 0.72) | 0.011 | 0.15 (0.04 to 0.54) | 0.003 |
Strongly disagree | 0.999 | 0.999 | ||
Exposure to COVID-19 information on the news and social media | 0.88 | – |
95% CI is displayed for variables with statistically significant differences.
IBD, inflammatory bowel disease.